Prasad, L.K., Smyth, H., 3D Printing technologies for drug delivery: a review. Drug Dev. Ind. Pharm. 42:7 (2016), 1019–1031, 10.3109/03639045.2015.1120743.
Sachs E., John, H., Michael, C., Paul, W. Three-dimensional printing techniques, US Patent 5,204,055;(19).
Infanger, S., Haemmerli, A., Iliev, S., Baier, A., Stoyanov, E., Quodbach, J., Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. Int. J. Pharm. 2019:555 (August 2018), 198–206, 10.1016/j.ijpharm.2018.11.048.
Xu, X., Robles-Martinez, P., Madla, C.M., Joubert, F., Goyanes, A., Basit, A.W., Gaisford, S., Stereolithography (SLA) 3D printing of an antihypertensive polyprintlet: Case study of an unexpected photopolymer-drug reaction. Addit. Manuf., 33, 2020, 101071, 10.1016/j.addma.2020.101071.
Fina, F., Goyanes, A., Gaisford, S., Basit, A.W., Selective laser sintering (SLS) 3D printing of medicines. Int. J. Pharm. 529:1–2 (2017), 285–293, 10.1016/j.ijpharm.2017.06.082.
El, A.I., Breitkreutz, J., Quodbach, J., Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications. Eur. J. Pharm. Sci., 146(February), 2020, 105266, 10.1016/j.ejps.2020.105266.
Pietrzak, K., Isreb, A., Alhnan, M.A., A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur. J. Pharm. Biopharm. 96:August (2015), 380–387, 10.1016/j.ejpb.2015.07.027.
Azad, M.A., Olawuni, D., Kimbell, G., Badruddoza, A.Z.M., Hossain, M.S., Sultana, T., Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials - Process Perspective. Pharmaceutics, 12(2), 2020, 124, 10.3390/pharmaceutics12020124.
Goyanes, A.A.A., Fina, F., Martorana, A., Sedough, D., Gaisford, S., Basit, A.W., Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int. J. Pharm. 527:1–2 (2017), 21–30, 10.1016/j.ijpharm.2017.05.021.
Kempin, W., Franz, C., Koster, L.-C., Schneider, F., Bogdahn, M., Weitschies, W., Seidlitz, A., Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur. J. Pharm. Biopharm. 115 (2017), 84–93, 10.1016/j.ejpb.2017.02.014.
Jonathan, G., Karim, A., 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int. J. Pharm. 499:1–2 (2015), 376–394, 10.1016/j.ijpharm.2015.12.071.
Feuerbach, T., Callau-Mendoza, S., Thommes, M., Development of Filaments for Fused Deposition Modeling 3D Printing with Medical Grade Poly(Lactic-Co-Glycolic Acid) Copolymers. Pharm. Dev. Technol. 24:4 (2019), 487–493, 10.1080/10837450.2018.1514522.
Lim, S.H., Kathuria, H., Tan, J.J.Y., Kang, L., 3D printed drug delivery and testing systems — a passing fad or the future ?. Adv. Drug Deliv. Rev. 132 (2018), 139–168, 10.1016/j.addr.2018.05.006.
Genina, N., Holländer, J., Jukarainen, H., Mäkilä, E., Salonen, J., Sandler, N., Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur. J. Pharm. Sci. 90 (2016), 53–63, 10.1016/j.ejps.2015.11.005.
Goyanes, A., Buanz, A.B.M., Basit, A.W., Gaisford, S., Fused- filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 476:1-2 (2014), 88–92, 10.1016/j.ijpharm.2014.09.044.
Goyanes, A., Wang, J., Buanz, A., Martínez-Pacheco, R., Telford, R., Gaisford, S., Basit, A.W., 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. Mol. Pharm. 12:11 (2015), 4077–4084, 10.1021/acs.molpharmaceut.5b00510.
Simões, M.F., Pinto, R.M.A., Simões, S., Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application. Drug Discov Today., 2019, 10.1016/j.drudis.2019.05.013.
Goyanes, A., Allahham, N., Tren, S., Stoyanov, E., Gaisford, S., Basit, 2019. A. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. 567(May). doi:10.1016/j.ijpharm.2019.118471.
Goyanes, A., Scarpa, M., Kamlow, M., Gaisford, S., Basit, A.W., Orlu, M., Patient acceptability of 3D printed medicines. Int. J. Pharm. 530:1-2 (2017), 71–78, 10.1016/j.ijpharm.2017.07.064.
Brissos, S., Veguilla, M.R., Taylor, D., Balanzá-Martinez, V., The role of long-acting injectable antipsychotics in schizophrenia: A critical appraisal. Ther. Adv. Psychopharmacol. 4:5 (2014), 198–219, 10.1177/2045125314540297.
de Leon, J., Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics. Neuropharmacology, 168, 2020, 107656, 10.1016/j.neuropharm.2019.05.033.
Leng, D., Chen, H., Li, G., Guo, M., Zhu, Z., Xu, L.u., Wang, Y., Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. Int. J. Pharm. 472:1-2 (2014), 380–385, 10.1016/j.ijpharm.2014.05.052.
Remenar, J.F., Making the leap from daily oral dosing to long-acting injectables: Lessons from the antipsychotics. Mol. Pharm. 11:6 (2014), 1739–1749, 10.1021/mp500070m.
Janssen, 2017. Invega Trinza.
Darville, N., van Heerden, M., Vynckier, A.n., De Meulder, M., Sterkens, P., Annaert, P., Van den Mooter, G., Intramuscular Administration of Paliperidone Palmitate Extended-Release Injectable Microsuspension Induces a Subclinical Inflammatory Reaction Modulating the Pharmacokinetics in Rats. Pharm. Drug Deliv. Pharm. Technol. 103:7 (2014), 2072–2087, 10.1002/jps.24014.
Nanaki, S., Tseklima, M., Terzopoulou, Z., Nerantzaki, M., Giliopoulos, D.J., Triantafyllidis, K., Kostoglou, M., Bikiaris, D.N., Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug. Eur. J. Pharm. Biopharm. 117 (2017), 77–90, 10.1016/j.ejpb.2017.03.016.
Elmowafy, M., Alruwaili, N.K., Shalaby, K., Alharbi, K.S., Altowayan, W.M., Ahmad, N., Zafar, A., Elkomy, M., Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; The Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity. Pharmaceutics, 12(2), 2020, 160, 10.3390/pharmaceutics12020160.
Stewart, S.A., Domínguez-Robles, J., McIlorum, V.J., Gonzalez, Z., Utomo, E., Mancuso, E., Lamprou, D.A., Donnelly, R.F., Larrañeta, E., Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs. Mol. Pharm. 17:9 (2020), 3487–3500, 10.1021/acs.molpharmaceut.0c00515.
Hao, W., Zheng, Z., Zhu, L., Pang, L., Ma, J., Zhu, S., Du, L., Jin, Y., 3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery. Asian J. Pharm. Sci. 16:1 (2021), 86–96, 10.1016/j.ajps.2020.06.002.
Domínguez-Robles, J., Shen, T., Cornelius, V.A., Corduas, F., Mancuso, E., Donnelly, R.F., Margariti, A., Lamprou, D.A., Larrañeta, E., Development of drug loaded cardiovascular prosthesis for thrombosis prevention using 3D printing. Mater. Sci. Eng., C, 129, 2021, 112375, 10.1016/j.msec.2021.112375.
Xu, X., Goyanes, A., Trenfield, S.J., Diaz-Gomez, L., Alvarez-Lorenzo, C., Gaisford, S., Basit, A.W., Stereolithography (SLA) 3D printing of a bladder device for intravesical drug delivery. Mater. Sci. Eng., C, 120, 2021, 111773, 10.1016/j.msec.2020.111773.
Ilyés, K., Kovács, N.K., Balogh, A., Borbás, E., Farkas, B., Casian, T., Marosi, G., Tomuță, I., Nagy, Z.K., The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation. Eur. J. Pharm. Sci. 129 (2019), 110–123, 10.1016/j.ejps.2018.12.019.
Trivedi, R.K., Jain, P., Patel, M.C., Chatrabhuji, P.M., Trivedi, D.R., 2013. A Rapid, Stability Indicating RP-UPLC Method for Determination of Paliperidone Palmitate in a Depot Injectable Formulation 3(07) 87-92. doi:10.7324/JAPS.2013.3716.
Bharathi, C.h., Chary, D.K., Kumar, M.S., Shankar, R., Handa, V.K., Dandala, R., Naidu, A., Identification, isolation and characterization of potential degradation product in risperidone tablets. J. Pharm. Biomed. Anal. 46:1 (2008), 165–169, 10.1016/j.jpba.2007.08.008.
Tümer, E.H., Erbil, H.Y., Extrusion-Based 3D Printing Applications of PLA Composites: A Review. Coatings 11 (2021), 1–42.
Li, D., Guo, G., Fan, R., Liang, J., Deng, X., Luo, F., Qian, Z., PLA/F68/Dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study. Int. J. Pharm. 441:1-2 (2013), 365–372, 10.1016/j.ijpharm.2012.11.019.
Dissolution Methods Database | FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/dissolution-methods-database. Accessed January 29, 2021.
Ruellan, A., Gratia, A., Guinault, A., et al. Bioproducts of oil industry as toughnening agents of Polylactide. Biopol, 2015, 13–15.
Xie, Y., Li, G., Yuan, X., Cai, Z., Rong, R., Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. AAPS PharmSciTech. 10:2 (2009), 631–640, 10.1208/s12249-009-9246-x.
Xiang, H., Wang, S., Wang, R., Zhou, Z., Peng, C., Zhu, M., Synthesis and characterization of an environmentally friendly PHBV/PEG copolymer network as a phase change material. Sci. China Chem. 56:6 (2013), 716–723, 10.1007/s11426-013-4837-5.
Boetker, J., Water, J.J., Aho, J., Arnfast, L., Bohr, A., Rantanen, J., Modifying release characteristics from 3D printed drug-eluting products. Eur. J. Pharm. Sci. 90 (2016), 47–52, 10.1016/j.ejps.2016.03.013.
Jamróz, W., Kurek, M., Czech, A., Szafraniec, J., Gawlak, K., Jachowicz, R., 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion. Eur. J. Pharm. Biopharm. 131 (2018), 44–47, 10.1016/j.ejpb.2018.07.017.
Huang, S., O'Donnell, K.P., Delpon de Vaux, S.M., O'Brien, J., Stutzman, J., Williams, R.O., Processing Thermally Labile Drugs by Hot-Melt Extrusion: The Lesson with Gliclazide. Eur. J. Pharm. Biopharm. 119 (2017), 56–67, 10.1016/j.ejpb.2017.05.014.
Desai, D., Sandhu, H., Shah, N., Malick, W., Zia, H., Phuapradit, W., Vaka, S.R.K., Selection of Solid-State Plasticizers as Processing Aids for Hot-Melt Extrusion. J. Pharm. Sci. 107:1 (2018), 372–379, 10.1016/j.xphs.2017.09.004.
Zhang, Y., Luo, R., Chen, Y., Ke, X., Hu, D., Han, M., Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. AAPS PharmSciTech. 15:3 (2014), 560–568, 10.1208/s12249-013-0071-x.
Yu, Y., Cheng, Y., Ren, J., Cao, E., Fu, X., Guo, W., Plasticizing effect of poly(ethylene glycol)s with different molecular weights in poly(lactic acid)/starch blends. J. Appl. Polym. Sci., 132(16), 2015, 10.1002/app.41808.
Lauer, M.E., Maurer, R., De, P.AT., et al. A Miniaturized Extruder to Prototype Amorphous Solid Dispersions: Selection of Plasticizers for Hot Melt Extrusion. Pharmaceutics, 10(58), 2018, 10.3390/pharmaceutics10020058.
Schneider, C., Langer, R., Loveday, D., Hair, D., Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems. J. Control. Release 262:August (2017), 284–295, 10.1016/j.jconrel.2017.08.004.
Allaf, R.M., Albarahmieh, E., AlHamarneh, B.M., Solid-state compounding of immiscible PCL-PEO blend powders for molding processes. J. Mech. Behav. Biomed. Mater. 97:February (2019), 198–211, 10.1016/j.jmbbm.2019.05.023.
de Brabander, C., van den Mooter, G., Vervaet, C., Remon, J.P., Characterization of Ibuprofen as a Nontraditional Plasticizer of Ethyl Cellulose. J. Pharm. Sci. 91:7 (2002), 1678–1685.
Islam, M.T., Scoutaris, N., Maniruzzaman, M., Moradiya, H.G., Halsey, S.A., Bradley, M.S.A., Chowdhry, B.Z., Snowden, M.J., Douroumis, D., Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing. Eur. J. Pharm. Biopharm. 96 (2015), 106–116, 10.1016/j.ejpb.2015.06.021.
Sarpal, K., Delaney, S., Zhang, G.G.Z., Munson, E.J., Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions. Mol. Pharm. 16:12 (2019), 4836–4851, 10.1021/acs.molpharmaceut.9b00731.
Bhugra, C., Telang, C., Schwabe, R., Zhong, L., Reduced crystallization temperature methodology for polymer selection in amorphous solid dispersions: Stability perspective. Mol. Pharm. 13:9 (2016), 3326–3333, 10.1021/acs.molpharmaceut.6b00315.
Marsac, P.J., Li, T., Taylor, L.S., Estimation of Drug – Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters. Pharm. Res. 26:1 (2009), 40–44, 10.1007/s11095-008-9721-1.
Moinuddin, S.M., Ruan, S., Huang, Y., Gao, Q., Shi, Q., Cai, B., Cai, T., Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile. Int. J. Pharm. 532:1 (2017), 393–400, 10.1016/j.ijpharm.2017.09.020.
Manini, G., Deldime, M., Benali, S., Raquez, J.-M., Goole, J., Long-acting implantable dosage forms containing paliperidone palmitate obtained by 3D printing. Int. J. Pharm., 603(May), 2021, 120702, 10.1016/j.ijpharm.2021.120702.
Grzybowska, K., Adrjanowicz, K., Paluch, M., Application of Broadband Dielectric Spectroscopy to Study Molecular Mobility in Pharmaceutical Systems. Disord. Pharm. Mater., 2016, 301–359.
Wang, B., Mathew, A., Napolitano, S., Temperature and Thickness Dependence of the Time Scale of Crystallization of Polymers under 1D Confinement. ACS Macro Lett. 10:4 (2021), 476–480, 10.1021/acsmacrolett.1c00123.
Simpson, S.M., Widanapathirana, L., Su, J.T., Sung, S., Watrous, D., Qiu, J., Pearson, E., Evanoff, A., Karunakaran, D., Chacon, J.E., Kiser, P.F., Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate. Pharm. Res., 37(4), 2020, 10.1007/s11095-020-2777-2.
Kleiner, L.W., Wright, J.C., Wang, Y., Evolution of implantable and insertable drug delivery systems. J. Control. Release 181:1 (2014), 1–10, 10.1016/j.jconrel.2014.02.006.
Kohno, M., Andhariya, J.V., Wan, B.o., Bao, Q., Rothstein, S., Hezel, M., Wang, Y., Burgess, D.J., The effect of PLGA molecular weight differences on risperidone release from microspheres. Int. J. Pharm., 582, 2020, 119339, 10.1016/j.ijpharm.2020.119339.
Rawat, A., Stippler, E., Shah, V.P., Burgess, D.J., Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. Int. J. Pharm. 420:2 (2011), 198–205, 10.1016/j.ijpharm.2011.08.035.
Shen, J., Lee, K., Choi, S., Qu, W., Wang, Y., Burgess, D.J., A reproducible accelerated in vitro release testing method for PLGA microspheres. Int. J. Pharm. 498:1–2 (2016), 274–282, 10.1016/j.ijpharm.2015.12.031.
Bode, C., Kranz, H., Fivez, A., Siepmann, F., Siepmann, J., Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants. J. Control. Release 306:May (2019), 97–107, 10.1016/j.jconrel.2019.05.039.
Khaled, S.A., Alexander, M.R., Irvine, D.J., Wildman, R.D., Wallace, M.J., Sharpe, S., Yoo, J., Roberts, C.J., Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry. AAPS PharmSciTech. 19:8 (2018), 3403–3413, 10.1208/s12249-018-1107-z.
Elbadawi, M., Muñiz Castro, B., Gavins, F.K.H., Ong, J.J., Gaisford, S., Pérez, G., Basit, A.W., Cabalar, P., Goyanes, A., M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines. Int. J. Pharm., 590, 2020, 119837, 10.1016/j.ijpharm.2020.119837.
Muñiz Castro, B., Elbadawi, M., Ong, J.J., Pollard, T., Song, Z., Gaisford, S., Pérez, G., Basit, A.W., Cabalar, P., Goyanes, A., Machine learning predicts 3D printing performance of over 900 drug delivery systems. J. Control. Release 337 (2021), 530–545, 10.1016/j.jconrel.2021.07.046.
Bhardwaj, U., Burgess, D.J., A novel USP apparatus 4 based release testing method for dispersed systems. Int. J. Pharm. 388:1–2 (2010), 287–294, 10.1016/j.ijpharm.2010.01.009.
Andhariya, J.V., Shen, J., Wang, Y., Choi, S., Burgess, D.J., Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres. Int. J. Pharm. 566:June (2019), 532–540, 10.1016/j.ijpharm.2019.06.014.
